Medical Clinics of North America-Periprocedural Antithrombotics: Prophylaxis and Interruption.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39341611.
- Also identified by DOI 10.1016/j.mcna.2024.04.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anticoagulation management in the surgical patient requires clinical expertise and careful attention. For patients already receiving anticoagulation for a defined indication (ie, stroke prevention for atrial fibrillation, treatment of venous thromboembolism (VTE), or presence of a mechanical heart valve), understanding how to manage these agents by weighing the risks of thromboembolic events and bleeding is paramount. Additionally, prevention of VTE in the surgical patient involves the identification of patient-specific and procedure-specific risk factors for both VTE and bleeding. With this information, as well as familiarity with the several antithrombotic options available, an appropriate prophylaxis strategy can be employed.
Medical subject headings
- Venous Thromboembolism
- Fibrinolytic Agents
- Anticoagulants